← Evidence map

ArticleCancer discovery2023

p53 Oligomerization Domain Mutants: A New Class of Mutants That Retain "License to Kill".

David Stieg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37139723